B-Cell CLL/lymphoma 2 (BCL2) Peptide
BCL2
Reactivity: Human
Host: Synthetic
BP
-
- Target See all Bcl-2 (BCL2) products
- Bcl-2 (BCL2) (B-Cell CLL/lymphoma 2 (BCL2))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-BCL2 Antibody reactivity.
-
B-Cell CLL/lymphoma 2 (BCL2) peptide
BCL2 Reactivity: Human, Mouse, Rat, Dog Host: Synthetic BP, Imm
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- Bcl-2 (BCL2) (B-Cell CLL/lymphoma 2 (BCL2))
- Synonyms
- Bcl-2 Peptide, PPP1R50 Peptide, bcl-2 Peptide, AW986256 Peptide, C430015F12Rik Peptide, D630044D05Rik Peptide, D830018M01Rik Peptide, BCL-2 Peptide, Bcl2 Peptide, BCL2, apoptosis regulator Peptide, B cell leukemia/lymphoma 2 Peptide, B-cell CLL/lymphoma 2a Peptide, B-cell CLL/lymphoma 2 protein Peptide, BCL2 Peptide, Bcl2 Peptide, bcl2a Peptide, BCL-2 Peptide
- Background
- Apoptosis regulator Bcl-2
- Gene ID
- 596
- UniProt
- P10415
-
You are here:
